Silgan Holdings Inc.

Silgan Holdings Inc. (SLGN) Market Cap

Silgan Holdings Inc. has a market capitalization of $3.87B.

Price: $36.63

0.35 (0.96%)

Market Cap: 3.87B

NYSE · time unavailable

CEO: Adam J. Greenlee

Sector: Consumer Cyclical

Industry: Packaging & Containers

IPO Date: 1997-02-14

Website: https://www.silganholdings.com

Silgan Holdings Inc. (SLGN) - Company Information

Market Cap: 3.87B|Sector: Consumer Cyclical

Company Profile

Silgan Holdings Inc., together with its subsidiaries, manufactures and sells rigid packaging for consumer goods products in North America, Europe, and internationally. It operates through three segments: Dispensing and Specialty Closures, Metal Containers, and Custom Containers. The Metal Containers segment manufactures and sells steel and aluminum containers for food products, such as pet food, vegetables, soups, proteins, tomato based products, adult nutritional drinks, fruits, and other miscellaneous food products, as well as general line metal containers primarily for chemicals. The Dispensing and Specialty Closures segment offers a range of metal and plastic closures, and dispensing systems for use in food, beverage, health care, garden, home, personal care, and beauty products, as well as capping/sealing equipment and detection systems. The Custom Containers segment manufactures and sells custom designed and stock plastic containers for use in personal care and health care; food and beverage; household and industrial chemical; pharmaceutical; pet food and care; agricultural; automotive; and marine chemical products. This segment also provides plastic thermoformed barrier and non-barrier bowls, and trays for food products, such as soups, other ready-to-eat meals, and pet food products; and plastic closures, caps, sifters, and fitments, as well as thermoformed tubs for food, household, and personal care products, including soft fabric wipes. The company markets its products primarily through direct sales force, as well as through a network of distributors and an online shopping catalog. Silgan Holdings Inc. was founded in 1987 and is headquartered in Stamford, Connecticut.

Analyst Sentiment

91%
Strong Buy

From 12 Active Polls

1Y Forecast: $50.50

▲ +37.9% Potential Upside

Consensus Target Metrics

Low Bound

$46

Median

$50

High Bound

$56

Average

$51

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$50.50
▲ +37.87% Upside
Low Target
$46.00
26% Risk
Median Target
$50.00
37% Mid
High Target
$56.00
53% Max
Consensus
Buy
14 / 21 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 11, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)3,8714,0974,2634,7465,7975,4655,5595,6074,472
Enterprise Value ($M)8,0968,3227,7999,30410,5329,7419,0939,0478,098
Price to Earnings Ratio (P/E)13.6516.2658.5610.4716.2920.1030.8414.0114.69
Price/Earnings-to-Growth Ratio (PEG)2.580.343.305.110.533.01
Price to Sales Ratio (P/S)0.592.622.902.363.773.733.943.213.24
Price to Book Ratio (P/B)1.671.771.872.092.612.622.792.732.31
Price to Free Cash Flow Ratio (P/FCF)12.61-4.653.4918.20-19.70-7.136.4322.21-126.74
Enterprise Value to Sales (EV/Sales)5.335.314.636.846.646.445.185.86
Enterprise Value to EBITDA (EV/EBITDA)8.4437.7436.4433.0443.2546.4153.3638.6639.06
Debt to Equity Ratio4.402.012.032.182.272.222.191.852.03

SLGN Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$36.63
Intrinsic Value$55.54
Market Alignment
Undervalued by 51.6%relative to calculated intrinsic value
9.00%
Exp: 6%6%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.79B
Perpetuity TV Value$14.92B
Discounted TV (PV)$6.30B
TV Weighting %61.1%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 SILGAN HOLDINGS INC (SLGN) — Investment Overview

🧩 Business Model Overview

Silgan designs and manufactures consumer packaging components, primarily focusing on rigid packaging and closures used by branded and private-label manufacturers. The business participates in a manufacturing value chain that links upstream materials (e.g., metals and plastics) to end-markets such as food, beverage, household, and personal care.

Operationally, Silgan’s model emphasizes integrated production across customer-specific SKUs (including engineered components), established quality systems for food-contact and safety requirements, and a sales approach built around service reliability. These dynamics translate into practical customer stickiness: packaging selections must meet strict specifications, run seamlessly through customer filling lines, and maintain consistent quality over long operating horizons—conditions that make vendor transitions expensive and operationally disruptive.

💰 Revenue Streams & Monetisation Model

Revenue is largely tied to unit volumes of packaging components sold under customer programs and supply arrangements. Monetisation is driven by:

  • Transactional unit economics with embedded contract behavior: Many orders behave like repeat programs due to requalification and line integration costs, though they remain influenced by end-demand cycles.
  • Margin capture through manufacturing efficiency: Cost discipline, plant utilization, scrap reduction, and process yield directly affect unit margins.
  • Cost pass-through and pricing mechanisms: Exposure exists to underlying materials (metals, resins), but pricing and indexing structures often help moderate margin volatility.
  • Product mix: Higher complexity and engineered components typically carry better margins than commoditized packaging runs.

Overall, Silgan’s economics are best understood as a combination of scale-driven manufacturing cost advantages and customer/program retention that converts a manufacturing base into repeat business.

🧠 Competitive Advantages & Market Positioning

Silgan’s moat is primarily switching-cost durability and scale-based cost advantages, supported by quality/intangible operating know-how.

  • High switching costs (qualification + line integration): Packaging components must be engineered to customer specifications and validated through production lines. Changes can require requalification, equipment tuning, and additional compliance documentation.
  • Operational scale and process capability: Economies of scale improve per-unit manufacturing cost and enable tighter quality control, yielding and lead-time performance that matters in high-throughput filling environments.
  • Quality and compliance as an intangible asset: Food-contact and safety requirements create barriers that favor established manufacturers with proven systems and track records.

Competitive benchmarking:

  • Ball Corporation and Crown Holdings (rigid packaging—beverage cans and related offerings): These competitors often emphasize beverage can production and scale in metal packaging. Silgan’s focus extends more broadly across consumer packaging components and closures, where vendor qualification and program execution also drive stickiness.
  • AptarGroup (closures and dispensing systems): Aptar is more concentrated on specialty closures and dispensing technologies. Silgan competes by offering manufactured packaging components with strong execution in program supply and customer qualification processes rather than purely proprietary dispensing innovation.

Relative to these rivals, Silgan’s positioning leans on breadth of packaging component capability, manufacturing execution, and durable customer relationships—advantages that make share shifts difficult even when end markets fluctuate.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by both secular end-market demand and Silgan’s ability to retain and win packaging programs:

  • Continuing substitution and demand for rigid packaging: Consumer goods increasingly rely on durable, shippable packaging formats suited to convenience, freshness, and shelf-life requirements.
  • Lightweighting and sustainability-linked design: Material efficiency (e.g., for metal packaging) and recyclable packaging structures support demand from brands seeking lower footprint per unit while maintaining performance.
  • Program wins driven by operational reliability: Customers prioritize suppliers that protect uptime and quality across high-volume filling lines; this favors established manufacturers with strong operational fundamentals.
  • Geographic and customer-footprint alignment: Manufacturing footprints that reduce logistics friction and improve service levels can support share retention and selective share gains.
  • Share shift within private-label and mixed-brand portfolios: As retailers and private-label brands refine product assortments, they often require consistent packaging supply and cost-effective production—an environment where scale and process control matter.

⚠ Risk Factors to Monitor

  • Input cost volatility: Exposure to metals and resins can pressure margins if pricing mechanisms fail to fully offset changes.
  • End-market cyclicality: Packaging volumes correlate with consumer packaged goods and industrial manufacturing throughput; demand downturns can reduce plant utilization and compress margins.
  • Customer concentration and contracting dynamics: Program renewals, competitive rebids, and contract pricing terms can affect profitability.
  • Capital intensity and execution risk: Maintaining capacity, technology, and quality systems requires ongoing capex; execution missteps can impact throughput and cost structure.
  • Regulatory and environmental compliance: Food-contact standards and sustainability regulations may require process changes and documentation costs, affecting compliance overhead.

📊 Valuation & Market View

Packaging industrials are typically valued using EV/EBITDA and free cash flow frameworks, reflecting cyclicality and the importance of margin stability. Key valuation drivers include:

  • Operating margin durability (unit economics, yield, and mix)
  • Cash conversion (working capital discipline and capex needs)
  • Plant utilization and pricing power through commodity cycles
  • Consistency of customer program retention (lower churn supports predictability)

Because this is a manufacturing-led business with end-market variability, valuation tends to expand when investors see sustained margins and disciplined capital deployment, and compress when volumes or spreads weaken.

🔍 Investment Takeaway

Silgan’s long-term case rests on durable switching costs created by packaging qualification and line integration, reinforced by scale-based manufacturing cost advantages and quality/compliance operating capabilities. In a sector where vendor transitions are operationally difficult and program execution matters, these moats can support resilient earnings power across packaging cycles—assuming management maintains cost discipline and effectively manages commodity and utilization risks.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for SLGN.

seekingalpha.com2026-06-05

Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

zacks.com2026-05-29

Why Is Silgan (SLGN) Down 6.3% Since Last Earnings Report?

Silgan (SLGN) reported earnings 30 days ago. What's next for the stock?

businesswire.com2026-05-12

Silgan Declares Quarterly Dividend

NORWALK, Conn.--(BUSINESS WIRE)--SILGAN DECLARES QUARTERLY DIVIDEND.

seekingalpha.com2026-04-29

Silgan Holdings Inc. (SLGN) Q1 2026 Earnings Call Transcript

Silgan Holdings Inc. (SLGN) Q1 2026 Earnings Call Transcript

zacks.com2026-04-29

Silgan (SLGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Silgan (SLGN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com2026-04-29

Silgan Holdings (SLGN) Q1 Earnings and Revenues Top Estimates

Silgan Holdings (SLGN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.82 per share a year ago.

businesswire.com2026-04-29

Silgan Announces First Quarter 2026 Results

NORWALK, Conn.--(BUSINESS WIRE)--SILGAN ANNOUNCES FIRST QUARTER 2026 RESULTS.

zacks.com2026-04-28

Avery Dennison Q1 Earnings Top Estimates on Volume Gains, Cost Control

AVY beats Q1 earnings estimates on strong volumes and cost control, with profits rising and cash flow swinging to positive despite mixed segment performance.

zacks.com2026-04-27

Crown Holdings (CCK) Q1 Earnings and Revenues Surpass Estimates

Crown Holdings (CCK) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.67 per share a year ago.

zacks.com2026-04-22

Analysts Estimate Silgan Holdings (SLGN) to Report a Decline in Earnings: What to Look Out for

Silgan (SLGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

reuters.com2026-04-17

Gerresheimer rejects takeover bid from US packing firm Silgan, say sources

German medical packaging maker Gerresheimer has rejected ​a takeover bid from its ‌U.S. rival Silgan , three sources familiar with the situation told ​Reuters.

zacks.com2026-04-15

Is the Options Market Predicting a Spike in Silgan Holdings Stock?

Investors need to pay close attention to SLGN stock based on the movements in the options market lately.

businesswire.com2026-04-10

Silgan to Release First Quarter 2026 Earnings Results on April 29, 2026

NORWALK, Conn.--(BUSINESS WIRE)--Silgan to Release First Quarter 2026 Earnings Results on April 29, 2026.

seekingalpha.com2026-04-02

Silgan Holdings: Strong Cash Flows Will Reduce Net Debt Fast

Silgan Holdings delivered robust 2025 results, with revenue up over 10% and EBIT rising 15% to nearly $600 million, driven by the Weener Plastics acquisition. SLGN generated about $400 million in free cash flow, comfortably covering its dividend and supporting rapid net debt reduction, despite net debt standing at 3.5x EBITDA. Guidance for 2026 targets $450 million in free cash flow and adjusted EPS of $3.7–$3.9, with a $500 million buyback program activated but not yet utilized.

reuters.com2026-03-20

US packaging firm Silgan signals interest for Germany's Gerresheimer, sources say

U.S. packaging company Silgan Holdings has signalled interest in taking over German ​medical packaging maker Gerresheimer GXIG.DE, according to ‌two sources familiar with the matter.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"Q1’26 results: Revenue was $1.561B and Net Income was $63.0M (EPS $0.60). On a YoY basis, revenue increased about +6.5% versus Q1’25 ($1.467B) and net income rose about -7.3% versus Q1’25 ($67.96M) (i.e., income declined despite higher sales). On a QoQ basis, revenue grew +6.4% versus Q4’25 ($1.469B) while net income surged +245.6% versus Q4’25 ($18.2M). Profitability softened across the 4-quarter sequence: gross margin drifted down (Q1’26 17.0% vs Q4’25 17.2%, and below stronger mid-year quarters ~19–16% depending on mix), and net margin also compressed to 4.0% from 1.2% in Q4’25 but well below Q3’25’s 5.6%. Operating income was $134.6M (8.6% margin) while interest expense remained notable ($41.4M). Cash flow quality deteriorated materially in Q1’26: operating cash flow was -$800M and free cash flow was -$882M, driven by large working-capital and non-cash items. The company did pay dividends ($22.8M), but no buybacks are shown. Balance sheet resilience remains strong in the quarter: cash jumped to $435M while reported total equity is not available in the dataset (0 reported), and total debt is not reported for Q1’26; therefore leverage assessment is limited. Total shareholder returns: the stock price is $41.99 and the provided 1y_change is -14.31% (below the +20% momentum threshold), which weighs on the overall score despite the positive EPS in Q1’26. Analyst valuation inputs (consensus target $48) suggest modest upside (~+14%)."

Revenue Growth

Neutral

Revenue rose +6.4% QoQ ($1.469B to $1.561B) and +6.5% YoY ($1.467B to $1.561B), indicating a steady top-line rebound heading into Q2.

Profitability

Caution

Net income declined about -7.3% YoY ($68.0M to $63.0M) while margins were choppy: net margin at 4.0% improved vs Q4’25 (1.2%) but remains below Q3’25 (5.6%) and other stronger periods.

Cash Flow Quality

Neutral

Operating cash flow was -$800M in Q1’26 and free cash flow -$882M, a sharp decline from Q4’25 where operating cash flow was +$1.29B. Dividend paid ($22.8M) occurred without offsetting operating cash in the quarter.

Leverage & Balance Sheet

Caution

Balance sheet fields are partially unavailable/zero in Q1’26 (equity reported as 0; debt not provided), limiting leverage assessment. Cash increased to $435M from $1.081B in Q4’25, but debt/solvency metrics cannot be reliably trended from this dataset.

Shareholder Returns

Caution

1y_change is -14.31% (no strong positive momentum). Dividend yield is ~0.56% based on the provided ratios; buybacks are not indicated for Q1’26.

Analyst Sentiment & Valuation

Neutral

Consensus price target is $48 vs current $41.99 (approx. +14% upside). Targets imply constructive sentiment, but near-term cash flow weakness tempers the rating.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

SLGN’s Q1 2026 shows resilient, pass-through-supported revenue growth (+6% net sales) but pressured earnings quality: adjusted EPS fell $0.04 to $0.78 as adjusted EBIT declined 4% and the tax rate rose, partly offset by lower interest. Management attributes core headwinds to severe North America weather, fruit/vegetable pre-buy effects, and mix/inventory dynamics (including Europe higher-cost inventory comparisons). On the upside, fragrance and beauty delivered another double-digit organic volume quarter, and metal containers posted pet food volume growth of 11%, supporting segment volumes (+2%). The company raised full-year adjusted EPS by $0.03 to $3.73–$3.93, confirming free cash flow ~ $450M (CapEx ~$310M). Near-term risk remains inflation timing: for Q2, dispensing expects ~$50M incremental resin-related cost translating to ~$10M adjusted EBIT impact, with recovery potentially lagging into Q4/2027 if resin softens.

AI IconGrowth Catalysts

  • Double-digit organic volume growth in fragrance and beauty dispensing products driven by market-leading innovation and customer partnership model
  • Metal containers pet food volume up 11% year-over-year supporting segment volume growth (overall metal volumes +2%)
  • Weener integration completed; management cites combined innovation engine runway for organic growth above market in dispensing and specialty closures
  • Custom containers expected inflection: volumes comparable to prior year on a reported basis after completed destocking and 2025 footprint/cost reduction exit effects

Business Development

  • New contractual win in 2026 already commercialized and embedded in 2026 volume outlook (fragrance/beauty dispensing performance mentioned as benefiting)
  • Weener portfolio fully integrated (described as integrated with Silgan innovation engines; enables share capture in fragrance and beauty launches)
  • M&A pipeline described as active for rigid packaging for consumer goods and higher-margin/higher-growth dispensing and specialty closures assets

AI IconFinancial Highlights

  • Net sales $1.6B, +6% year-over-year driven by contractual pass-through of higher raw material costs (mostly metal containers) and favorable foreign currency translation
  • Total adjusted EBIT $152M, down 4% year-over-year; management attributed lower dispensing & specialty closures and custom containers EBIT and higher corporate expense partially offset by higher metal container adjusted EBITDA
  • Adjusted EPS $0.78, down $0.04 year-over-year; decline attributed to lower adjusted EBIT and higher tax rate, partially offset by lower interest expense
  • Weather-driven volume and product-mix disruption: severe North America weather curtailing customer production impacted both volumes and mix
  • 2026 outlook raised: adjusted EPS increased $0.03 to $3.73–$3.93 (vs $3.72 in 2025), reflecting strong Q1 operational EBIT performance
  • Q2 2026 guidance: adjusted EPS $0.92–$1.02; interest expense $50M; tax rate 25%–26%
  • Resin/inflation impact: expecting ~$50M incremental cost in Q2 in dispensing & specialty closures related to Middle East conflict, impacting adjusted EBIT by approximately $10M
  • Free cash flow confirmed ~ $450M for 2026 with CapEx ~ $310M

AI IconCapital Funding

  • Buyback/debt specifics not quantified in transcript; management reiterated M&A return-hurdle framework requires acquisitions to clear capital-allocation alternatives (buybacks or debt paydown)
  • No new debt balance figures disclosed; integration of prior ~$1B Weener acquisition described with deleveraging plan completed within ~15 months

AI IconStrategy & Ops

  • Custom Containers: continued footprint optimization cost reduction plan with exited lower-margin business; destocking carried into and concluded during Q1 2026
  • Metal Containers: timing shift logic—manufacturing 'hands all year' but fruit/vegetable order/consumption timing moved toward Q3 based on crop packing/field timing (large customer ownership change altered product fill/consumption profile)
  • Inflation management: sourcing strategy emphasizes buying/manufacturing/selling within one geography to reduce customer-level exposure to global price shocks

AI IconMarket Outlook

  • Full-year 2026 volume expectations largely unchanged: Dispensing & specialty closures low-to-mid single-digit organic volume mix growth (driven by mid-single-digit dispensing growth)
  • Metal Containers volumes expected to grow low single-digit: mid-single-digit pet food growth and stable human food
  • Custom Containers volumes expected comparable to prior year on reported basis; second-half growth expected as new business ramps after prior destocking and cost-reduction exits
  • Q2 2026: dispensing & specialty closures adjusted EBIT expected comparable to prior year with significant inflation offsetting volume growth; metal containers adjusted EBIT expected below prior year due to seasonal normalization in fruit/vegetables
  • 2026 adjusted EPS range: $3.73–$3.93; weighted average share count ~106M

AI IconRisks & Headwinds

  • Severe North America weather in Q1 curtailed customer production and volumes; also adversely affected mix
  • Resin inflation tied to Middle East conflict: expected ~$50M incremental cost in Q2 with ~$10M adjusted EBIT impact
  • Fruit and vegetable market pre-buy: expected impacts from customer purchasing ahead of 2026 raw material inflation weighed on Q1 volumes and drives normalization later
  • Metal containers fruit/vegetable timing and order pattern shift: altered seasonal profile due to customer ownership change and timing of shipments/consumption
  • Europe inventory cost headwinds: dispensing & specialty closures adjusted EBIT comparisons affected by selling prior-year inventory benefit in 2025 vs higher-cost 2026 steel/food & beverage inventory in Europe

Q&A: Analyst Interest

  • Topic: Metal Containers 3Q/seasonality timing and weather vs guidance. Management explained the timing shift is driven by a large fruit-and-vegetable customer’s new ownership changing the shipment/consumption profile, moving product filling closer to crop packing. They emphasized manufacturing runs all year and full-year volumes are unchanged.
  • Topic: Dispensing resin inflation pass-through, magnitude, and when impact reverses. Management quantified ~$50M incremental Q2 cost (Middle East-related) translating to ~$10M adjusted EBIT impact. They said the net impact isn’t ideally recoverable in Q2/Q3; recovery depends on resin market declines and may extend into Q4 and 2027.
  • Topic: Healthcare applications growth and commercialization footprint. Management cited expanded growth in nasal and ophthalmic applications with capacity investment behind the target. They stated the health care business is closer to ~$250M now versus ~$200M earlier, and sees application opportunities expanding within nasal/ophthalmic beyond just current programs.

Sentiment: MIXED

Note: This summary was synthesized by AI from the SLGN Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for SLGN.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (SLGN)

© 2026 Stock Market Info — Silgan Holdings Inc. (SLGN) Financial Profile